Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the
gastrointestinal tract, characterized by an inflammatory process that requires lifelong …

The diet and gut microbiota have been extensively interrogated as a fuel for gut
inflammation in inflammatory bowel diseases (IBDs) in the last few years. Here, we review …

MCC950 a potent, highly specific small molecule inhibitor of canonical and noncanonical
activation of NLRP3 inflammasome has been evaluated in a multitude of NLRP3 driven …

Inflammatory bowel disease (IBD) is defined as a chronic intestinal inflammation that results
from host-microbial interactions in a genetically susceptible individual. IBDs are a group of …

NOD-like receptor protein 3 (NLRP3), an important intracellular pattern recognition receptor,
is a component of the NLRP3 inflammasome along with apoptosis-associated speck-like …

Inflammatory bowel disease is a heterogeneous group of chronic disorders that result from
the interaction of the intestinal immune system with the gut microbiome. Until recently, most …

Background Fecal calprotectin (FC) is a promising biomarker for diagnosis of inflammatory
bowel disease (IBD). However, the utility of FC for assessment of IBD activity has yet to be …

Background Vitamin D plays a role in several immune-mediated diseases, but its
association with inflammatory bowel disease (IBD) is unclear. We conducted a systematic …

This review aimed to summarize the epidemiology (incidence, prevalence and morality) and
risk factors of inflammatory bowel disease (IBD). IBD is a chronic, relapsing, inflammatory …

Phytochemicals are known to have anti-inflammatory effects in vitro and in vivo, such as in
inflammatory disease model systems. Inflammation is an essential immune response to …